As senior country officer for China, Li will be responsible for JPMorgan’s businesses and products in the country, according to the memo, which was confirmed by Marie Cheung, a Hong Kong-based spokeswoman. Li, who was also previously UBS’s country head for China, will join JPMorgan in October and be based in Beijing, the document showed.
Li replaces Zili Shao, JPMorgan’s former China chairman and chief executive officer, who was named the bank’s Asia-Pacific vice chairman in April. Fang Fang, the company’s CEO of investment banking for China, resigned in March after more than 12 years at the firm amid an investigation by U.S. regulators into its Asian hiring practices.
Shao, who joined JPMorgan in 2009, oversaw a China expansion that included the formation of a domestic securities venture, buying stakes in a trust and a guarantee company, and establishing a locally incorporated bank. Li spent nine years at Zurich-based UBS and helped set up UBS Securities Co., the firm’s Chinese brokerage venture, of which he was chairman until he left the company.
“We’ve been building the platform and now a strong infrastructure is in place,” Nicolas Aguzin, JPMorgan’s chairman and CEO for the Asia-Pacific region, said in a phone interview today. “The mandate that he has is to really put it all together.”
Li, who will report to Aguzin, used to work at Citigroup Inc. in New York. He has a masters of business administration from the Wharton School at the University of Pennsylvania, according to JPMorgan’s memo.
“The fundamental transformation that people expect in China over the next 10 to 15 years will result in substantial opportunities, whether it’s renminbi and interest-rate liberalization, the development of the middle class, or capital market reform,” Aguzin said. “There’s so much to do and that’s what he will focus on.”
JPMorgan’s business in China includes investment banking, asset management and transaction banking. It does most of its wholesale commercial and corporate banking through its locally incorporated lender.
The U.S. probes that started last year posed hurdles to JPMorgan’s involvement in at least two China investment-banking transactions.
The bank quit China Everbright Bank Co.’s $3 billion Hong Kong share sale in November because the investigation delayed internal approval, according to two people with knowledge of the matter. In January, it bowed out of Tianhe Chemicals Group Ltd.’s initial public offering as questions arose over the bank’s previous employment of the daughter of Tianhe’s chairman, two people with knowledge of the matter said.
JPMorgan, the world’s biggest investment bank by fees last year, said in August that the Securities and Exchange Commission had sought information on its employment of certain people in Hong Kong and client relationships. The bank hasn’t been charged with any wrongdoing.
To contact the reporter on this story: Cathy Chan in Hong Kong at firstname.lastname@example.org
To contact the editors responsible for this story: Chitra Somayaji at email@example.com Russell Ward, Darren Boey